Religare Writes a New Chapter: ₹15,000 Crore in Convertible Confidence

Religare Enterprises Ltd (REL) has sanctioned a massive capital infusion proposal, the sale of 63.8 million convertible warrants at Rs 235 a warrant. This is a part of a bigger fund-raising proposal of up to Rs 15 billion to support financial services business and spur growth in subsidiaries.

Key Highlights

The warrants, on conversion, will be issued as capital shares, boosting the capital base of REL

Total potential proceeds of the warrant issue are approximately Rs 15 billion

The capital increase will finance expansion in SME finance, health insurance, retail broking, and affordable housing

REL's board further approved leadership and governance structure modifications to remain aligned with its growth blueprint

Strategic Context

REL is the corporate parent for Religare Finvest Ltd, Care Health Insurance Ltd, Religare Broking Ltd, and Religare Housing Development Finance Corp

The funds will be used for expansion, digitalization, and regulatory compliance

Part of it can be earmarked for Religare Finvest debt restructuring, which is under RBI's corrective action plan

The action comes following recent interest from marquee investors such as the Burman family and Ares SSG Capital

Market Implications

Analysts see the release of the warrant as a vote of confidence in REL's restructuring plan

Pricing conveys optimism regarding future valuation and shareholder returns

Investors are looking for execution transparency and metrics at the subsidiary level

Sources: Economic Times, Business Standard, Religare Enterprises Board Filings, BSE India, Moneycontrol